Skip to content
OpenCapital
Get started

Jazz Pharmaceuticals JAZZ Xyrem — Number of patents, paragraph IV certification notice filed

Similar metrics at other companies

Viatris logo
VTRSLyrica ® — Net Sales
$120.6M+7.1%
Biogen logo
BIIBRITUXAN — After GAZYVA First Non-CLL FDA Approval until First GAZYVA Threshold Date
39%0.0pp
Cytokinetics logo
CYTKReldesemtiv — Number Of Clinical Trials Conducted
0.5—
Viatris logo
VTRSEffexor ® — Net Sales
$62M+4.6%
Biogen logo
BIIBRITUXAN — Until Second GAZYVA Threshold Date
37.5%0.0pp
Johnson & Johnson logo
JNJXARELTO — Percent Change (as a percent)
-7%-40.3pp

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio2×-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept jazz:NumberOfPatentsParagraphIVCertificationNoticeFiled.

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's xyrem — number of patents, paragraph iv certification notice filed.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's xyrem — number of patents, paragraph IV certification notice filed?
Jazz Pharmaceuticals (JAZZ) reported xyrem — number of patents, paragraph IV certification notice filed of 7 in Q1 2026.
What does xyrem — number of patents, paragraph IV certification notice filed mean?
The number of legal notices received from generic competitors attempting to challenge the patents of a specific drug.
How do you interpret xyrem — number of patents, paragraph IV certification notice filed?
An increase indicates heightened legal challenges and a higher risk of generic market entry, which is negative for long-term revenue sustainability.
How does xyrem — number of patents, paragraph IV certification notice filed compare across companies?
Commonly reported by specialty pharmaceutical companies facing patent cliffs for blockbuster drugs.